Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE25.8800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots25.4000/ 1
- Ask / Lots28.1100/ 1
- Open / Previous Close0.0000 / 25.8800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 24980 | 26.11 |
| 09:34 ET | 1739 | 26.21 |
| 09:36 ET | 1918 | 26.18 |
| 09:38 ET | 5960 | 26.16 |
| 09:39 ET | 12910 | 26.18 |
| 09:41 ET | 700 | 26.225 |
| 09:43 ET | 4867 | 26.155 |
| 09:45 ET | 1936 | 26.11 |
| 09:48 ET | 900 | 26.12 |
| 09:50 ET | 2623 | 26.1 |
| 09:52 ET | 2873 | 26.07 |
| 09:54 ET | 3270 | 26.07 |
| 09:56 ET | 10443 | 26.06 |
| 09:57 ET | 2621 | 26.0658 |
| 09:59 ET | 12202 | 26.02 |
| 10:01 ET | 8014 | 25.99 |
| 10:03 ET | 1720 | 25.98 |
| 10:06 ET | 13274 | 25.95 |
| 10:08 ET | 1900 | 25.99 |
| 10:10 ET | 2613 | 25.9659 |
| 10:12 ET | 2860 | 25.965 |
| 10:14 ET | 16994 | 25.955 |
| 10:15 ET | 1731 | 25.96 |
| 10:17 ET | 41018 | 25.985 |
| 10:19 ET | 303 | 25.985 |
| 10:21 ET | 13134 | 25.995 |
| 10:24 ET | 2601 | 26.04 |
| 10:26 ET | 4069 | 26.06 |
| 10:28 ET | 10732 | 26.05 |
| 10:30 ET | 4853 | 26.08 |
| 10:32 ET | 27900 | 26.01 |
| 10:33 ET | 3079 | 26 |
| 10:35 ET | 2091 | 25.99 |
| 10:37 ET | 2573 | 26.005 |
| 10:39 ET | 2000 | 26.01 |
| 10:42 ET | 18887 | 25.985 |
| 10:44 ET | 14602 | 25.9948 |
| 10:46 ET | 3324 | 26.01 |
| 10:48 ET | 2174 | 26.045 |
| 10:50 ET | 3369 | 26.05 |
| 10:51 ET | 2617 | 26.0411 |
| 10:53 ET | 1537 | 26.04 |
| 10:55 ET | 5400 | 26.045 |
| 10:57 ET | 7088 | 26.065 |
| 11:00 ET | 4917 | 26.05 |
| 11:02 ET | 7792 | 26.095 |
| 11:04 ET | 1732 | 26.095 |
| 11:06 ET | 2566 | 26.08 |
| 11:08 ET | 8904 | 26.06 |
| 11:09 ET | 1558 | 26.045 |
| 11:11 ET | 700 | 26.04 |
| 11:13 ET | 3112 | 26.055 |
| 11:15 ET | 900 | 26.05 |
| 11:18 ET | 8253 | 26.045 |
| 11:20 ET | 4070 | 26.0699 |
| 11:22 ET | 3957 | 26.06 |
| 11:24 ET | 200 | 26.055 |
| 11:26 ET | 5199 | 26.04 |
| 11:27 ET | 9428 | 26.04 |
| 11:29 ET | 4108 | 26.04 |
| 11:31 ET | 3397 | 26.01 |
| 11:33 ET | 7160 | 26.02 |
| 11:36 ET | 5058 | 26.02 |
| 11:38 ET | 6035 | 26.025 |
| 11:40 ET | 2826 | 26.01 |
| 11:42 ET | 4507 | 26.02 |
| 11:44 ET | 2097 | 26.005 |
| 11:45 ET | 1100 | 26.005 |
| 11:47 ET | 8207 | 26.015 |
| 11:49 ET | 4679 | 26.03 |
| 11:51 ET | 1925 | 26.03 |
| 11:54 ET | 6005 | 26.04 |
| 11:56 ET | 5317 | 26.06 |
| 11:58 ET | 2500 | 26.035 |
| 12:00 ET | 5453 | 26.045 |
| 12:02 ET | 5730 | 26.05 |
| 12:03 ET | 2249 | 26.04 |
| 12:05 ET | 800 | 26.03 |
| 12:07 ET | 2156 | 26.04 |
| 12:09 ET | 4208 | 26.045 |
| 12:12 ET | 5884 | 26.065 |
| 12:14 ET | 3400 | 26.06 |
| 12:16 ET | 7213 | 26.065 |
| 12:18 ET | 9898 | 26.04 |
| 12:20 ET | 4776 | 26.0323 |
| 12:21 ET | 969 | 26.035 |
| 12:23 ET | 1387 | 26.035 |
| 12:25 ET | 13550 | 26.06 |
| 12:27 ET | 14986 | 26.06 |
| 12:30 ET | 8122 | 26.055 |
| 12:32 ET | 9030 | 26.05 |
| 12:34 ET | 2533 | 26.04 |
| 12:36 ET | 3910 | 26.0275 |
| 12:38 ET | 3901 | 26.005 |
| 12:39 ET | 2007 | 26 |
| 12:41 ET | 1268 | 26 |
| 12:43 ET | 5622 | 26 |
| 12:45 ET | 6546 | 26.02 |
| 12:48 ET | 1258 | 26.015 |
| 12:50 ET | 2453 | 26.015 |
| 12:52 ET | 1358 | 26.015 |
| 12:54 ET | 2774 | 26.005 |
| 12:56 ET | 20233 | 25.985 |
| 12:57 ET | 5132 | 25.95 |
| 12:59 ET | 8782 | 25.96 |
| 01:01 ET | 2230 | 25.97 |
| 01:03 ET | 2669 | 25.975 |
| 01:06 ET | 1663 | 25.975 |
| 01:08 ET | 700 | 25.977 |
| 01:10 ET | 1059 | 25.975 |
| 01:12 ET | 6944 | 26 |
| 01:14 ET | 573 | 26 |
| 01:15 ET | 211 | 26.01 |
| 01:17 ET | 655 | 26.005 |
| 01:19 ET | 1100 | 26.005 |
| 01:21 ET | 5617 | 25.98 |
| 01:24 ET | 3486 | 25.98 |
| 01:26 ET | 4160 | 25.97 |
| 01:28 ET | 35570 | 25.95 |
| 01:30 ET | 4813 | 25.95 |
| 01:32 ET | 1358 | 25.94 |
| 01:33 ET | 6018 | 25.945 |
| 01:35 ET | 500 | 25.935 |
| 01:37 ET | 400 | 25.935 |
| 01:39 ET | 600 | 25.93 |
| 01:42 ET | 4186 | 25.925 |
| 01:44 ET | 10630 | 25.925 |
| 01:46 ET | 7188 | 25.895 |
| 01:48 ET | 9682 | 25.905 |
| 01:50 ET | 1600 | 25.905 |
| 01:51 ET | 2138 | 25.89 |
| 01:53 ET | 2162 | 25.895 |
| 01:55 ET | 3044 | 25.895 |
| 01:57 ET | 5392 | 25.885 |
| 02:00 ET | 15809 | 25.885 |
| 02:02 ET | 5299 | 25.875 |
| 02:04 ET | 1091 | 25.8739 |
| 02:06 ET | 4771 | 25.865 |
| 02:08 ET | 2422 | 25.875 |
| 02:09 ET | 7707 | 25.86 |
| 02:11 ET | 1100 | 25.865 |
| 02:13 ET | 12789 | 25.855 |
| 02:15 ET | 23676 | 25.885 |
| 02:18 ET | 1925 | 25.885 |
| 02:20 ET | 7809 | 25.865 |
| 02:22 ET | 8046 | 25.86 |
| 02:24 ET | 14463 | 25.885 |
| 02:26 ET | 6576 | 25.9 |
| 02:27 ET | 9312 | 25.915 |
| 02:29 ET | 3075 | 25.91 |
| 02:31 ET | 1945 | 25.905 |
| 02:33 ET | 3496 | 25.895 |
| 02:36 ET | 6797 | 25.905 |
| 02:38 ET | 1700 | 25.925 |
| 02:40 ET | 1445 | 25.925 |
| 02:42 ET | 4071 | 25.895 |
| 02:44 ET | 3636 | 25.89 |
| 02:45 ET | 1047 | 25.89 |
| 02:47 ET | 2264 | 25.89 |
| 02:49 ET | 1644 | 25.89 |
| 02:51 ET | 4540 | 25.885 |
| 02:54 ET | 11964 | 25.885 |
| 02:56 ET | 9597 | 25.885 |
| 02:58 ET | 15053 | 25.875 |
| 03:00 ET | 3464 | 25.8873 |
| 03:02 ET | 793 | 25.885 |
| 03:03 ET | 17062 | 25.915 |
| 03:05 ET | 1200 | 25.915 |
| 03:07 ET | 3650 | 25.925 |
| 03:09 ET | 10348 | 25.945 |
| 03:12 ET | 2273 | 25.94 |
| 03:14 ET | 1112 | 25.93 |
| 03:16 ET | 7693 | 25.92 |
| 03:18 ET | 4598 | 25.955 |
| 03:20 ET | 5493 | 25.965 |
| 03:21 ET | 7916 | 25.98 |
| 03:23 ET | 2350 | 25.98 |
| 03:25 ET | 3131 | 25.985 |
| 03:27 ET | 1909 | 25.975 |
| 03:30 ET | 6773 | 25.96 |
| 03:32 ET | 8758 | 25.95 |
| 03:34 ET | 5019 | 25.94 |
| 03:36 ET | 5381 | 25.93 |
| 03:38 ET | 7494 | 25.935 |
| 03:39 ET | 5507 | 25.925 |
| 03:41 ET | 1248 | 25.925 |
| 03:43 ET | 56244 | 25.93 |
| 03:45 ET | 4994 | 25.955 |
| 03:48 ET | 3712 | 25.955 |
| 03:50 ET | 4986 | 25.935 |
| 03:52 ET | 12931 | 25.915 |
| 03:54 ET | 31781 | 25.89 |
| 03:56 ET | 45668 | 25.845 |
| 03:57 ET | 34674 | 25.85 |
| 03:59 ET | 55420 | 25.88 |
Jun 4, 2024
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesRoyalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesDJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 15.5B | 14.5x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -11.6x | --- |
Catalent Inc | 10.2B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.6B | 21.7x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.4B | 16.4x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.5B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.25% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.5x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | 13.0x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
